Sort
48,018 grants matching “immunotherapy”
Small molecule inhibitors of Slit2/Robo signaling as novel therapeutics for glioblastoma
$548,232Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Utilizing MEK Inhibition to Sensitize Microsatellite Stable Colorectal Cancer to Immune Checkpoint Therapy
$548,097Christopher Hanyoung Lieu · University Of Colorado Denver · R01 · FY2020 · CA
Overcoming primary and secondary resistance in wild-type BRAF melanoma
$548,033Andrew E Aplin · Wistar Institute · P01 · FY2020 · CA
SMALL ANIMAL MULTI-MODALITY IMAGING CENTER (SAMMIC)
$547,922University Of Pennsylvania · R24 · FY2001 · CA
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
$547,911James R. Heath · Institute For Systems Biology · R01 · FY2022 · CA
Antigenic determinants of asthma-associated allergens for design of immunotherapy
$547,850Anna Pomes · Indoor Biotechnologies · R01 · FY2022 · AI
Predicting Relapse at the Time of Diagnosis in Acute Lymphoblastic Leukemia
$547,763Kara Lynn Davis · Stanford University · R01 · FY2024 · CA
ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE
$547,729Heather L Stevenson · University Of Texas Med Br Galveston · R01 · FY2022 · DK
Small molecule inhibitors of Slit2/Robo signaling as novel therapeutics for glioblastoma
$547,687Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Identification of REV-ERB inverse agonists for cancer immunotherapy
$547,678Laura A Solt · Scripps Florida · R01 · FY2019 · CA
Functional and Therapeutic Significance of PLK4 in Melanoma
$547,582Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2025 · CA
Functional and Therapeutic Significance of PLK4 in Melanoma
$547,582Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2022 · CA
Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment
$547,576Laurie McLouth · University Of Kentucky · R01 · FY2023 · CA
The role of natural killer cells and antibodies in protection from malaria
$547,557Geoffrey T Hart · University Of Minnesota · R01 · FY2021 · AI
Dissecting the Kaposi Sarcoma Tumor Microenvironment at the Single Cell Level
$547,525Warren Phipps · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Leveraging Biologically Specific PET/MRI Monitoring and Therapeutic Modulation of the Hypoxic Glioblastoma Tumor Immune Microenvironment into Improved Outcomes
$547,519Ramon Francisco Barajas · Oregon Health & Science University · R37 · FY2024 · CA
Strategies to predict and overcome resistance to cancer immunotherapy
$547,492Steven L Reiner · Columbia University Health Sciences · R01 · FY2023 · CA
Strategies to predict and overcome resistance to cancer immunotherapy
$547,492Steven L Reiner · Columbia University Health Sciences · R01 · FY2025 · CA
Negative regulation of myeloid-derived suppressive cells in cancer
$547,478Yulia Nefedova · Wistar Institute · R01 · FY2020 · CA
Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer
$547,420Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2022 · CA
Metabolic Regulation ofPD-L1 in CD11c+ Cells
$547,418Cong Yan · Indiana University Indianapolis · R01 · FY2019 · CA
SUMOylation disruption is toxic for SS18-SSX-driven synovial sarcoma
$547,288Anthony Charles Faber · Virginia Commonwealth University · R01 · FY2025 · CA
Deciphering the molecular control of intratumoral dendritic cells
$547,265Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Deployable Ultrasound Applicators for MRI Guided Thermal Therapy of Pancreatic Cancer
$547,262Chris John Diederich · University Of California, San Francisco · R01 · FY2022 · EB
Computational imaging approaches to personalized gastric cancer treatment
$547,185Ruijiang Li · Stanford University · R01 · FY2024 · CA